Literature DB >> 23640137

Neurocognitive functioning and health-related quality of life in patients with radiologically suspected meningiomas.

D van Nieuwenhuizen1, N Ambachtsheer, J J Heimans, J C Reijneveld, S M Peerdeman, M Klein.   

Abstract

Few data are available concerning the neurocognitive outcome and health-related quality of life (HRQOL) following neurosurgery in meningioma patients, and even less is known about neurocognitive functioning and HRQOL in untreated patients with stable lesions. The present study aims at quantifying the nature and extent of neurocognitive deficits and HRQOL in suspected WHO grade I meningioma patients who have not received surgery and/or radiotherapy and compare outcome to that of healthy controls. Neurocognitive functioning was assessed by using a standardized test battery in 21 radiologically suspected WHO grade I meningioma patients with a wait-and-scan approach. HRQOL was assessed with the MOS SF-36 questionnaire. These patients were matched for age, sex, and education with 21 healthy controls. Associations between neurocognitive functioning on the one hand and HRQOL and tumor characteristics on the other were determined. Compared to healthy controls, meningioma patients had lower psychomotor speed (p = 0.011) and working memory capacity (p = 0.034) and furthermore attained lower levels of self-perceived general health and vitality. Neurocognitive functioning in untreated patients was not related to tumor volume, edema or tumor lateralization. No correlations were found between psychomotor speed or working memory and HRQOL. Untreated meningioma patients with stable lesions have limitations in neurocognitive functioning and HRQOL. In deciding upon a treatment strategy these reductions in functioning should be taken into consideration and communicated with the patient.

Entities:  

Mesh:

Year:  2013        PMID: 23640137     DOI: 10.1007/s11060-013-1132-4

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  39 in total

1.  The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires.

Authors:  D Osoba; N K Aaronson; M Muller; K Sneeuw; M A Hsu; W K Yung; M Brada; E Newlands
Journal:  Qual Life Res       Date:  1996-02       Impact factor: 4.147

2.  Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations.

Authors:  N K Aaronson; M Muller; P D Cohen; M L Essink-Bot; M Fekkes; R Sanderman; M A Sprangers; A te Velde; E Verrips
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

3.  The role of working memory in visual selective attention.

Authors:  J W de Fockert; G Rees; C D Frith; N Lavie
Journal:  Science       Date:  2001-03-02       Impact factor: 47.728

4.  Long-term impact of cognitive deficits and epilepsy on quality of life in patients with low-grade meningiomas.

Authors:  Martin L Waagemans; David van Nieuwenhuizen; Monica Dijkstra; Miriam Wumkes; Clemens M F Dirven; Sieger Leenstra; Jaap C Reijneveld; Martin Klein; Lukas J A Stalpers
Journal:  Neurosurgery       Date:  2011-07       Impact factor: 4.654

5.  Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study.

Authors:  M Klein; J J Heimans; N K Aaronson; H M van der Ploeg; J Grit; M Muller; T J Postma; J J Mooij; R H Boerman; G N Beute; G J Ossenkoppele; G W van Imhoff; A W Dekker; J Jolles; B J Slotman; H Struikmans; M J B Taphoorn
Journal:  Lancet       Date:  2002-11-02       Impact factor: 79.321

6.  Quality of life in patients with intracranial tumors on the basis of Karnofsky's performance status.

Authors:  W Sachsenheimer; W Piotrowski; T Bimmler
Journal:  J Neurooncol       Date:  1992-06       Impact factor: 4.130

Review 7.  Epidemiology of intracranial meningioma.

Authors:  W T Longstreth; L K Dennis; V M McGuire; M T Drangsholt; T D Koepsell
Journal:  Cancer       Date:  1993-08-01       Impact factor: 6.860

8.  Incidental meningiomas in autopsy study.

Authors:  S Nakasu; A Hirano; T Shimura; J F Llena
Journal:  Surg Neurol       Date:  1987-04

9.  Late neurocognitive sequelae in patients with WHO grade I meningioma.

Authors:  M Dijkstra; D van Nieuwenhuizen; L J A Stalpers; M Wumkes; M Waagemans; W P Vandertop; J J Heimans; S Leenstra; C M Dirven; J C Reijneveld; M Klein
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-07-24       Impact factor: 10.154

10.  Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life.

Authors:  Martin Klein; Nadine H J Engelberts; Henk M van der Ploeg; Dorotheé G A Kasteleijn-Nolst Trenité; Neil K Aaronson; Martin J B Taphoorn; Hans Baaijen; W Peter Vandertop; Martin Muller; Tjeerd J Postma; Jan J Heimans
Journal:  Ann Neurol       Date:  2003-10       Impact factor: 10.422

View more
  18 in total

1.  Work productivity and neuropsychological function in persons with skull base tumors.

Authors:  Bethany D Nugent; Jason Weimer; Chienwen J Choi; Cathy J Bradley; Catherine M Bender; Christopher M Ryan; Paul Gardner; Paula R Sherwood
Journal:  Neurooncol Pract       Date:  2014-09

Review 2.  Impaired health-related quality of life in meningioma patients-a systematic review.

Authors:  Amir H Zamanipoor Najafabadi; Marthe C M Peeters; Linda Dirven; Daniel J Lobatto; Justus L Groen; Marieke L D Broekman; Saskia M Peerdeman; Wilo C Peul; Martin J B Taphoorn; Wouter R van Furth
Journal:  Neuro Oncol       Date:  2017-07-01       Impact factor: 12.300

3.  Neurocognition in individuals with incidentally-identified meningioma.

Authors:  Alissa M Butts; Stephen Weigand; Paul D Brown; Ronald C Petersen; Clifford R Jack; Mary M Machulda; Jane H Cerhan
Journal:  J Neurooncol       Date:  2017-05-25       Impact factor: 4.130

4.  Cognitive improvement in meningioma patients after surgery: clinical relevance of computerized testing.

Authors:  Ikram Meskal; Karin Gehring; Sophie D van der Linden; Geert-Jan M Rutten; Margriet M Sitskoorn
Journal:  J Neurooncol       Date:  2014-12-11       Impact factor: 4.130

5.  Prevalence, correlates, and impact of sleep disturbance in Chinese meningioma patients.

Authors:  Dandan Zhang; Jing Wang; Xixi Gu; Zhifeng Gu; Liren Li; Chen Dong; Rui Zhao; Xiaomei Zhang
Journal:  Support Care Cancer       Date:  2021-08-30       Impact factor: 3.359

6.  Life after surgical resection of a meningioma: a prospective cross-sectional study evaluating health-related quality of life.

Authors:  Farshad Nassiri; Benjamin Price; Ameer Shehab; Karolyn Au; Michael D Cusimano; Michael D Jenkinson; Christine Jungk; Alireza Mansouri; Thomas Santarius; Suganth Suppiah; Ken X Teng; Gurvinder S Toor; Gelareh Zadeh; Tobias Walbert; Katharine J Drummond
Journal:  Neuro Oncol       Date:  2019-01-14       Impact factor: 12.300

7.  Multiple Meningioma in a Patient of Bipolar Disorder: The Dilemma of Detecting Structural Brain Lesions in the Backdrop of a Long Standing Psychiatric Illness.

Authors:  Ananya Mahapatra; Mamta Sood; Sudhir Kumar Khandelwal
Journal:  J Clin Diagn Res       Date:  2016-08-01

8.  Prevalence of perceived cognitive dysfunction in survivors of a wide range of cancers: results from the 2010 LIVESTRONG survey.

Authors:  John E Schmidt; Ellen Beckjord; Dana H Bovbjerg; Carissa A Low; Donna M Posluszny; Amy E Lowery; Mary Amanda Dew; Stephanie Nutt; Sarah R Arvey; Ruth Rechis
Journal:  J Cancer Surviv       Date:  2015-08-04       Impact factor: 4.442

9.  Surgery in elderly patients with intracranial meningioma: neuropsychological functioning during a long term follow-up.

Authors:  Andrea Di Cristofori; Barbara Zarino; Giulio Bertani; Marco Locatelli; Paolo Rampini; Giorgio Carrabba; Manuela Caroli
Journal:  J Neurooncol       Date:  2018-01-12       Impact factor: 4.130

10.  EANO guideline on the diagnosis and management of meningiomas.

Authors:  Roland Goldbrunner; Pantelis Stavrinou; Michael D Jenkinson; Felix Sahm; Christian Mawrin; Damien C Weber; Matthias Preusser; Giuseppe Minniti; Morten Lund-Johansen; Florence Lefranc; Emanuel Houdart; Kita Sallabanda; Emilie Le Rhun; David Nieuwenhuizen; Ghazaleh Tabatabai; Riccardo Soffietti; Michael Weller
Journal:  Neuro Oncol       Date:  2021-11-02       Impact factor: 13.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.